I-BASF ne-Balchem ​​zithole imvumo ye-US Food and Drug Administration (FDA) yokusebenzisa i-Amasil formic acid ekudleni kweenkukhu e-US.
I-BASF ne-Balchem ​​zithole imvumo ye-US Food and Drug Administration (FDA) yokusebenzisa i-Amasil formic acid ekudleni kweenkukhu e-US.
I-Amasil isanda kwethulwa bona isetjenziselwe iingulube e-United States begodu sele isetjenziswe ngepumelelo ekudleni kweenkukhu ephasini loke. Ithathwa njenge-esidi ye-organic ephumelela khulu yokwenza ukudla kube ne-esidi.
Ngokwehlisa i-pH yokudla, i-Amasil yenza indawo engakalungi yamabhaktheriya, ngaleyo ndlela yehlisa inani lamagciwane athwala ukudla begodu yehlisa ukuthathwa kwama-microbial. Ukwehlisa i-pH godu kwehlisa amandla we-buffer, ngaleyo ndlela kukhuphule ukusebenza kuhle kwama-enzayimu amanengi wokugaya ukudla, lokho kwenza ngcono ukusebenza kuhle nokukhula kokudla.
"I-Amasil ine-molecular density ephezulu khulu kunanoma ngiyiphi i-organic acid evunyelwe yi-US begodu inikela ngenani elihle khulu lokudla," kutjho u-Christian Nitschke, umphathi we-North America e-BASF Animal Nutrition. "Nge-Balchem, nje sesingaletha iinzuzo ze-Amasil kibo boke abakhiqizi beenkukhu nenyama yefarigi e-North America."
"Sithabile khulu ngethuba elitjha lokuthinta ukusebenza kuhle kokudla nokukhula kwamakhasimende wethu weenkukhu," kutjho u-Tom Powell, umnqophisi wokukhiqizwa kwe-monogastric e-Balchem ​​Animal Nutrition & Health. okulindelweko. Isidingo sokudla okuphephileko.”